Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature.

Grubb KJ, Kennedy JL, Bergin JD, Groves DS, Kern JA.

J Thorac Cardiovasc Surg. 2012 Nov;144(5):e113-6. doi: 10.1016/j.jtcvs.2012.07.030. Epub 2012 Sep 13. Review. No abstract available.

2.

Methylene blue, serotonergic syndrome, and heart transplant.

Evora PR.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):897. doi: 10.1016/j.jtcvs.2012.11.090. No abstract available.

3.

Methylene blue in patients with severe pulmonary hypertension.

Hajj-Chahine J, Jayle C, Corbi P.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):898. doi: 10.1016/j.jtcvs.2012.11.091. No abstract available.

4.

Reply to the editor.

Grubb KJ, Kennedy JL, Bergin JD, Groves DS, Kern JA.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):898-9. doi: 10.1016/j.jtcvs.2012.12.063. No abstract available.

5.

Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.

Lenglet S, Mach F, Montecucco F.

Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1519-25. doi: 10.1586/erc.11.160. Review.

PMID:
22103871
6.

Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome.

Hencken L, To L, Ly N, Morgan JA.

J Card Surg. 2016 Apr;31(4):208-10. doi: 10.1111/jocs.12705. Epub 2016 Mar 2.

PMID:
26934199
7.

Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.

Mink SN, Kasian K, Santos Martinez LE, Jacobs H, Bose R, Cheng ZQ, Light RB.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1724-35. doi: 10.1152/ajpheart.01072.2007. Epub 2008 Feb 8.

PMID:
18263714
8.

A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.

Manghelli J, Brown L, Tadros HB, Munfakh NA.

Tex Heart Inst J. 2015 Oct 1;42(5):491-4. doi: 10.14503/THIJ-14-4470. eCollection 2015 Oct.

9.

Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.

Farina Junior JA, Celotto AC, da Silva MF, Evora PR.

Med Sci Monit. 2012 May;18(5):HY13-7. Review.

10.

Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.

Samlowski WE, Kondapaneni M, Tharkar S, McGregor JR, Laubach VE, Salvemini D.

J Immunother. 2011 Jun;34(5):419-27. doi: 10.1097/CJI.0b013e31821dcb50.

PMID:
21577143
12.

[Septic shock and NO].

Mitaka C.

Nihon Rinsho. 2004 Sep;62 Suppl 9:540-3. Review. Japanese. No abstract available.

PMID:
15506445
13.

[Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].

Ng BK, Cameron AJ, Liang R, Rahman H.

Can J Anaesth. 2008 Jan;55(1):36-41. doi: 10.1007/BF03017595. Review.

PMID:
18166746
14.

Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.

Carley M, Schaff J, Lai T, Poppers J.

A A Case Rep. 2015 Oct 15;5(8):127-30. doi: 10.1213/XAA.0000000000000190.

PMID:
26466303
15.

Fatal methylene blue associated serotonin toxicity.

Top WM, Gillman PK, de Langen CJ, Kooy A.

Neth J Med. 2014 Apr;72(3):179-81.

16.

Methylene blue encephalopathy: a case report and review of published cases.

Shopes E, Gerard W, Baughman J.

AANA J. 2013 Jun;81(3):215-21. Review.

PMID:
23923673
17.

Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.

Evora PR, Ribeiro PJ, Vicente WV, Reis CL, Rodrigues AJ, Menardi AC, Alves Junior L, Evora PM, Bassetto S.

Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):279-88. Review.

PMID:
20011872
18.

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease.

Stasch JP, Pacher P, Evgenov OV.

Circulation. 2011 May 24;123(20):2263-73. doi: 10.1161/CIRCULATIONAHA.110.981738. Review. No abstract available.

19.

Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.

Toque HA, Mónica FZ, Morganti RP, De Nucci G, Antunes E.

Eur J Pharmacol. 2010 Oct 25;645(1-3):158-64. doi: 10.1016/j.ejphar.2010.07.028. Epub 2010 Jul 27.

PMID:
20670622
20.

Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.

Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ.

Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H184-92. doi: 10.1152/ajpheart.00181.2009. Epub 2010 Apr 30.

Supplemental Content

Support Center